Company Profiles

driven by the PitchBook Platform

Archer Pharmaceuticals

Archer Pharmaceuticals
2008 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$150K LATEST DEAL AMOUNT
Description

Developer of drugs for Alzheimer's disease. The company is engage din the research and development of Nilvadipine as a therapeutic for Alzheimer's Disease.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 2040 Whitfield Avenue
  • Sarasota, FL 34243
  • United States

+1 (941) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Archer Pharmaceuticals’s full profile, request a free trial.

Archer Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Sep-2011 $150K 00.00 Completed Startup
1. Early Stage VC (Series A) 08-Dec-2008 00.00 00.00 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Archer Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 0.000
To view this company’s complete Cap Table, request access »

Archer Pharmaceuticals Executive Team (3)

Name Title Board
Seat
Contact
Info
Michael Mullan MD Chief Executive Officer, Chief Scientific Officer & Board Member
Jerry Smith Chief Financial Officer
Fiona Crawford Ph.D Chief Technology Officer & Associate Chief Scientific Officer

Archer Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
Michael Mullan MD Archer Pharmaceuticals Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000